Form 4 Filing for NEUROCRINE BIOSCIENCES INC

This filing details a transaction by Christine A. Poon, a director at NEUROCRINE BIOSCIENCES INC (NBIX). On May 27, 2026, Ms. Poon acquired 2,567 Restricted Stock Units (RSUs) with a post-transaction share count of 2,567. The RSUs, representing the right to receive one share of common stock upon vesting, will fully vest on May 27, 2027. The transaction was reported on Form 4, with the signature date of May 29, 2026.